These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 23583722)
1. Key issues in phage therapy: a report of a dedicated workshop at the Viruses of Microbes II meeting. Huys I; Vaneechoutte M; Verbeken G; Debarbieux L Res Microbiol; 2013 Sep; 164(7):806-10. PubMed ID: 23583722 [No Abstract] [Full Text] [Related]
2. European regulatory conundrum of phage therapy. Verbeken G; De Vos D; Vaneechoutte M; Merabishvili M; Zizi M; Pirnay JP Future Microbiol; 2007 Oct; 2(5):485-91. PubMed ID: 17927471 [TBL] [Abstract][Full Text] [Related]
3. A bacteriophage journey at the European Medicines Agency. Debarbieux L; Pirnay JP; Verbeken G; De Vos D; Merabishvili M; Huys I; Patey O; Schoonjans D; Vaneechoutte M; Zizi M; Rohde C FEMS Microbiol Lett; 2016 Jan; 363(2):fnv225. PubMed ID: 26656541 [TBL] [Abstract][Full Text] [Related]
4. [Phage therapy: harmless viruses help destroy bacterial infections]. van Bergen M; Wagenaar J Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):618-21. PubMed ID: 18767304 [No Abstract] [Full Text] [Related]
5. Experience of the Eliava Institute in bacteriophage therapy. Kutateladze M Virol Sin; 2015 Feb; 30(1):80-1. PubMed ID: 25662889 [No Abstract] [Full Text] [Related]
6. Bacteriophages as twenty-first century antibacterial tools for food and medicine. Maura D; Debarbieux L Appl Microbiol Biotechnol; 2011 May; 90(3):851-9. PubMed ID: 21491205 [TBL] [Abstract][Full Text] [Related]
7. Introduction to special issue on viruses and microbes. Toussaint A; Prangishvili D; Molineux IJ Virology; 2012 Dec; 434(2):137. PubMed ID: 23217985 [No Abstract] [Full Text] [Related]
8. Bacteriophages as an alternative strategy for fighting biofilm development. Parasion S; Kwiatek M; Gryko R; Mizak L; Malm A Pol J Microbiol; 2014; 63(2):137-45. PubMed ID: 25115107 [TBL] [Abstract][Full Text] [Related]
9. Computational models of populations of bacteria and lytic phage. Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960 [TBL] [Abstract][Full Text] [Related]
10. Phage therapies for plants and people. Gross M Curr Biol; 2014 Jun; 24(12):R541-4. PubMed ID: 25075391 [TBL] [Abstract][Full Text] [Related]
11. Profile of Paul E. Turner. Viegas J Proc Natl Acad Sci U S A; 2020 Aug; 117(32):18906-18908. PubMed ID: 32747551 [No Abstract] [Full Text] [Related]
12. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens. Viertel TM; Ritter K; Horz HP J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344 [TBL] [Abstract][Full Text] [Related]
13. Perspective: The age of the phage. Matsuzaki S; Uchiyama J; Takemura-Uchiyama I; Daibata M Nature; 2014 May; 509(7498):S9. PubMed ID: 24784429 [No Abstract] [Full Text] [Related]
17. Stronger together? Perspectives on phage-antibiotic synergy in clinical applications of phage therapy. Segall AM; Roach DR; Strathdee SA Curr Opin Microbiol; 2019 Oct; 51():46-50. PubMed ID: 31226502 [TBL] [Abstract][Full Text] [Related]
18. Bacteriophages, revitalized after 100 years in the shadow of antibiotics. Wei H Virol Sin; 2015 Feb; 30(1):1-2. PubMed ID: 25680442 [No Abstract] [Full Text] [Related]
19. Paving a regulatory pathway for phage therapy. Europe should muster the resources to financially, technically and legally support the introduction of phage therapy. Huys I; Pirnay JP; Lavigne R; Jennes S; De Vos D; Casteels M; Verbeken G EMBO Rep; 2013 Nov; 14(11):951-4. PubMed ID: 24136414 [No Abstract] [Full Text] [Related]
20. Programming Bacteriophages by Swapping Their Specificity Determinants. Goren MG; Yosef I; Qimron U Trends Microbiol; 2015 Dec; 23(12):744-746. PubMed ID: 26526502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]